QPS
Mark McDonald is an experienced executive in the clinical research industry, currently serving as Executive Director and Head of US Clinical Business Development at QPS Holdings, LLC since May 2013. McDonald is responsible for selling Phase I services across QPS' five clinics located in the US, Netherlands, India, and Taiwan. Prior to this role, McDonald held various positions including Account Director at PRA International, and Sr. Director of Business Development at Qualia Clinical Services, where responsibilities included managing business development teams and overseeing clinical operations. McDonald began a career in clinical research at Harris Labs and holds a B.S. in Biological Sciences from the University of Nebraska-Lincoln.
This person is not in any offices
QPS
QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. An award-winning leader focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities. We are passionate about our work, creating value for patients and customers while generating opportunities for employees to thrive.